Header Logo

Connection

ZHUYONG MEI to Thymidine Kinase

Back to Details
This is a "connection" page, showing publications ZHUYONG MEI has written about Thymidine Kinase.
ZHUYONG MEI
Connection Strength
0.052
Thymidine Kinase
  1. A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2022 10 14; 28(20):4392-4401.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.